Lisa C. McClain
RHouseRepresentative · Michigan
N
Bought up to $15,000 of Novo Nordisk (NVO)
Trade dated Oct 30, 202522 days to disclose
NVO since the buy
-12.6%
S&P 500, same window
+11.4%
▼ NVO trailed the S&P 500 by 23.9 points since the buy
Price move from the trade date's close to the most recent close. A buy is favorable when the stock rose after.
⚑ Committee jurisdiction
Lisa C. McClain sits on Health, Employment, Labor, and Pensions, which oversees the Pharmaceutical sector. This trade fell in that sector while Lisa C. McClain held the seat. STOCK Act trades are legal; this is a structural overlap on the public record.
On the public record around this trade
Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.
- Sep 17, 2025CommitteeH.R. 1723 the "Tribal Labor Sovereignty Act"; H.R. 2958 the "Balance the Scales Act"; H.R. 2869 the "EBSA Investigations Transparency Act"; H.R. 2844 the "Michael Enzi Voluntary Protection Program Act"; H.R. 3495 the "Direct Seller and Real Estate Agent Harmonization Act"; H.R. 5169 the "Retire through Ownership Act"
- Oct 30, 2025TradeBought up to $15,000 of NVO
- Nov 21, 2025DisclosureDisclosed the tradePublic filing
- Dec 17, 2025Floor voteResult: Failed
- Dec 17, 2025Floor voteResult: Passed
- Dec 18, 2025Floor voteResult: Failed
- Dec 18, 2025Floor voteResult: Passed
Get an alert the moment Lisa C. McClain files the next one
Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.